79 related articles for article (PubMed ID: 12149309)
1. Challenging cases and diagnostic dilemmas: case 2. Pitfalls of positron emission tomography for assessing residual mediastinal mass after chemotherapy for Hodgkin's disease.
Bomanji JB; Syed R; Brock C; Jankowska P; Dogan A; Costa DC; Ell PJ; Lee SM
J Clin Oncol; 2002 Aug; 20(15):3347-9. PubMed ID: 12149309
[No Abstract] [Full Text] [Related]
2. Failure of fluorodeoxyglucose positron emission tomography to detect the high-grade transformation of nodular lymphocyte predominant Hodgkin's lymphoma.
Puyade M; Yacoub M; Tomowiak C; Diviné M; Perdrisot R; Guilhot F; Delwail V
Acta Haematol; 2013; 129(4):229-31. PubMed ID: 23328622
[No Abstract] [Full Text] [Related]
3. False-positive F-18 FDG gamma camera positron emission tomographic imaging resulting from inflammation of an anterior mediastinal mass in a patient with non-Hodgkin's lymphoma.
Yoon SN; Park CH; Kim MK; Hwang KH; Kim S
Clin Nucl Med; 2001 May; 26(5):461-2. PubMed ID: 11317035
[No Abstract] [Full Text] [Related]
4. Nephrotic syndrome leading to the diagnosis of classical Hodgkin's lymphoma in a 13-year-old girl.
Escobar H; Yoshimi A; Hoffmann R; van Buiren M; Wild D; Folkens JU; Pohl M; Kontny U
Klin Padiatr; 2012 Apr; 224(3):191-2. PubMed ID: 22513794
[No Abstract] [Full Text] [Related]
5. Mediastinal sarcoidosis mimicking lymph malignancy recurrence after anti-neoplastic therapy.
El Hammoumi M; El Marjany M; Moussaoui D; Doudouh A; Mansouri H; Kabiri el H
Arch Bronconeumol; 2015 Jul; 51(7):e33-5. PubMed ID: 25294405
[TBL] [Abstract][Full Text] [Related]
6. [Sarcoidosis-like reaction after treatment with doxorubicin, bleomycin, vinblastine and dacarbazine in a patient with Hodgkin's lymphoma].
Torrent A; Navarro JT; Andreo FC; Ribera JM
Med Clin (Barc); 2013 Aug; 141(3):134-5. PubMed ID: 23332624
[No Abstract] [Full Text] [Related]
7. Assessment of tumor size reduction improves outcome prediction of positron emission tomography/computed tomography after chemotherapy in advanced-stage Hodgkin lymphoma.
Kobe C; Kuhnert G; Kahraman D; Haverkamp H; Eich HT; Franke M; Persigehl T; Klutmann S; Amthauer H; Bockisch A; Kluge R; Wolf HH; Maintz D; Fuchs M; Borchmann P; Diehl V; Drzezga A; Engert A; Dietlein M
J Clin Oncol; 2014 Jun; 32(17):1776-81. PubMed ID: 24799482
[TBL] [Abstract][Full Text] [Related]
8. Challenging cases and diagnostic dilemmas: case 1. Tracheal compression in Hodgkin's disease.
Garrison MA; Glanton C; Rasnke M; Smith ME; Ornstein DL
J Clin Oncol; 2002 Aug; 20(15):3344-7. PubMed ID: 12149308
[No Abstract] [Full Text] [Related]
9. The significance of a residual mediastinal mass following treatment for aggressive non-Hodgkin's lymphomas.
Tredaniel J; Brice P; Lepage E; Bris C; Marolleau JP; Ferme C; Hennequin C; Fermand JP; Frija J; Gisselbrecht C
Eur Respir J; 1992 Feb; 5(2):170-3. PubMed ID: 1559581
[TBL] [Abstract][Full Text] [Related]
10. An Unusual Presentation of Cervical Carcinoma Metastasis as Mediastinal Adenopathy.
Chaddha U; Patil PD; English R; Panchabhai TS
J Bronchology Interv Pulmonol; 2017 Oct; 24(4):e61-e63. PubMed ID: 28957900
[No Abstract] [Full Text] [Related]
11. Prognostic value of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose ([18F]FDG) after first-line chemotherapy in non-Hodgkin's lymphoma: is [18F]FDG-PET a valid alternative to conventional diagnostic methods?
Spaepen K; Stroobants S; Dupont P; Van Steenweghen S; Thomas J; Vandenberghe P; Vanuytsel L; Bormans G; Balzarini J; De Wolf-Peeters C; Mortelmans L; Verhoef G
J Clin Oncol; 2001 Jan; 19(2):414-9. PubMed ID: 11208833
[TBL] [Abstract][Full Text] [Related]
12. Positron emission tomography / computerized tomography evaluation of primary Hodgkin's disease of liver.
Gota VS; Purandare NC; Gujral S; Shah S; Nair R; Rangarajan V
Indian J Cancer; 2009; 46(3):237-9. PubMed ID: 19574678
[TBL] [Abstract][Full Text] [Related]
13. [The choice of chemotherapy under PET/CT-guided treatment de-escalation has a significant impact on fertility and quality of life in young Hodgkin's lymphoma patients].
Guninski RS; Balermpas P
Strahlenther Onkol; 2022 Aug; 198(8):752-754. PubMed ID: 35459961
[No Abstract] [Full Text] [Related]
14. Mediastinal granuloma: a rare cause of dysphagia.
Micic D; Hogarth DK; Kavitt RT
BMJ Case Rep; 2016 Jun; 2016():. PubMed ID: 27302638
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease.
Subbiah V
N Engl J Med; 2008 Feb; 358(7):743; author reply 743. PubMed ID: 18283721
[No Abstract] [Full Text] [Related]
16. Prognostic value of PET using 18F-FDG in Hodgkin's disease for posttreatment evaluation.
Guay C; Lépine M; Verreault J; Bénard F
J Nucl Med; 2003 Aug; 44(8):1225-31. PubMed ID: 12902411
[TBL] [Abstract][Full Text] [Related]
17. PET predicts prognosis after 1 cycle of chemotherapy in aggressive lymphoma and Hodgkin's disease.
Kostakoglu L; Coleman M; Leonard JP; Kuji I; Zoe H; Goldsmith SJ
J Nucl Med; 2002 Aug; 43(8):1018-27. PubMed ID: 12163626
[TBL] [Abstract][Full Text] [Related]
18. [18F]fluorodeoxyglucose positron emission tomography in the management of lymphomas.
Kostakoglu L
Clin Lymphoma Myeloma; 2008 Oct; 8(5):273-6. PubMed ID: 18854280
[No Abstract] [Full Text] [Related]
19. Impact of positive positron emission tomography on prediction of freedom from progression after Stanford V chemotherapy in Hodgkin's disease.
Advani R; Maeda L; Lavori P; Quon A; Hoppe R; Breslin S; Rosenberg SA; Horning SJ
J Clin Oncol; 2007 Sep; 25(25):3902-7. PubMed ID: 17664458
[TBL] [Abstract][Full Text] [Related]
20. Expert opinions on positron emission tomography and computed tomography imaging in lymphoma.
Delbeke D; Stroobants S; de Kerviler E; Gisselbrecht C; Meignan M; Conti PS
Oncologist; 2009; 14 Suppl 2():30-40. PubMed ID: 19819922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
